EPITOPE SUMMARY
ALWEIQQVV is a linear peptidic epitope (epitope ID
2998
) studied as part of Replicase polyprotein 1ab (UniProt:P0DTD1) from SARS-CoV2, Replicase polyprotein 1a (UniProt:P0DTC1) from SARS-CoV2, Replicase polyprotein 1a (UniProt:P0C6U8) from SARS-CoV1 and Replicase polyprotein 1ab (UniProt:P0C6X7) from SARS-CoV1. This epitope has been studied for immune reactivity in
25
publication(s), tested in
37
T cell assays and
35
MHC ligand assays.
CURATED EXPERIMENTAL DATA
MHC Ligand Assay(s)
35
MHC moleculePositive / All
HLA-A*02:01
8
/
8
HLA-A*02:02
2
/
2
HLA-A*02:03
2
/
2
HLA-A*02:06
2
/
2
HLA-A*68:02
2
/
2
HLA-B*15:01
1
/
2
HLA-A*01:01
0
/
2
HLA-A*03:01
0
/
2
HLA-B*07:02
0
/
2
HLA-B*40:01
0
/
2
HLA-B*58:01
0
/
2
HLA-A*69:01
1
/
1
HLA-A*11:01
0
/
1
HLA-A*24:02
0
/
1
HLA-A*26:01
0
/
1
HLA-A*31:01
0
/
1
HLA-B*08:01
0
/
1
HLA-B*27:05
0
/
1
T Cell Assay(s)
37
Assay TypePositive / All
qualitative binding
16
/
18
IFNg release
6
/
12
T cell binding
3
/
3
activation
2
/
2
cytotoxicity
1
/
2
EXTERNAL RESOURCES
ResourceLink
IEDB-AR: MHC-I Processing
Predict MHC class I processing
IEDB-AR: MHC-I
Predict MHC class I binding affinity
IEDB-AR: B cell scales
Predict B cell epitopes